Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumab

by Saskia Räuber, Alice Willison, Melanie Korsen, Tristan Kölsche, Kristin S. Golombeck, Benedikt Plaack, Julia Schüller, Niklas Huntemann, Leoni Rolfes, Christina B. Schroeter, Christopher Nelke, Liesa Regner-Nelke, Moritz Förster, Marius Ringelstein, Marius Ringelstein, Michael Harry Barnett, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Orhan Aktas, Philipp Albrecht, Tobias Ruck, Nico Melzer, Sven G. Meuth, David Kremer
Published 2022-12-01